RT @CBDivaHealth: “this study suggest that CB1 receptor, CB2 receptor, and MAGL are closely related to the neuropathological processes of P…
RT @CBDivaHealth: “this study suggest that CB1 receptor, CB2 receptor, and MAGL are closely related to the neuropathological processes of P…
“this study suggest that CB1 receptor, CB2 receptor, and MAGL are closely related to the neuropathological... https://t.co/GWa2wPMzKv
“this study suggest that CB1 receptor, CB2 receptor, and MAGL are closely related to the neuropathological processes of PD, thus the pharmacological modulation of these targets could represent a new therapeutic tool for the management of Parkinson's.” http
RT @SEICannabinoide: Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Pat…
RT @SEICannabinoide: Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Pat…
RT @SEICannabinoide: Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Pat…
RT @SEICannabinoide: Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Pat…
RT @NeuroGen_papers: PubMed: Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Gangli…
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease. https://t.co/VPoXp42fML
PubMed: Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease. https://t.co/38yqAoNpco